Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastrointestinal medications.

Gary H Wynn1, Neil B Sandson, Kelly L Cozza

  • 1Walter Reed Army Medical Center, Washington, DC, USA. ghwynn@gmail.com

Psychosomatics
|January 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoinduction and suzetrigine: potential clinical implications.

Pain management·2026
Same author

Obtaining and Documenting Informed Consent: An Advanced UME Cross-Specialty, Role-Playing Skill Builder.

MedEdPORTAL : the journal of teaching and learning resources·2026
Same author

Posttraumatic Stress Disorder and Increased Incidence of Cardiovascular Disease: Independent Effects and Moderation of Risk by Comorbidities, Sex, and Age.

Biopsychosocial science and medicine·2025
Same author

Building Faculty Performance Evaluation from the Ground-Up: Designing Tools and Gauging Acceptance.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2025
Same author

Suzetrigine-Induced Metabolism of Factor Xa Inhibitors May Increase Risk of Thrombosis in Perioperative and Pain Patients.

Anesthesia and analgesia·2025
Same author

PTSD, Comorbidities, Gender, and Increased Risk of Cardiovascular Disease in a Large Military Cohort.

medRxiv : the preprint server for health sciences·2024
Same journal

Clinical Approach to Personality Change Due to Another Medical Condition.

Psychosomatics·2021
Same journal

Clonazepam for Catatonia Incompletely Responsive to lorazepam.

Psychosomatics·2021
Same journal

Diabetic Retinopathy and Depression: A Risk Assessment.

Psychosomatics·2021
Same journal

WITHDRAWN: Psychosis: A Presentation of COVID-19?

Psychosomatics·2021
Same journal

Dermatitis Neglecta, the Cognitive Assessment, and Micronutrients.

Psychosomatics·2020
Same journal

Coronavirus and Its Implications for Psychiatry: A Rapid Review of the Early Literature.

Psychosomatics·2020
See all related articles

This study reviews common gastrointestinal drugs, detailing their metabolism, interactions, and effects of genetic variations on drug efficacy and interactions. Understanding these factors is crucial for safe and effective patient treatment.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Genetics

Background:

  • Gastrointestinal (GI) medications are frequently prescribed.
  • Commonly used GI drugs include proton pump inhibitors (PPIs), H2 blockers, and 5-HT3 receptor antagonists.
  • Understanding drug metabolism and interactions is vital for patient safety.

Purpose of the Study:

  • To elucidate the metabolic pathways of common GI medications.
  • To detail drug-drug interactions, including those with psychotropic agents.
  • To explore the impact of genetic variations on GI drug effectiveness and interactions.

Main Methods:

  • Review of literature on GI drug metabolism and pharmacokinetics.
  • Analysis of drug interactions with P-glycoprotein transporter.

Related Experiment Videos

  • Examination of enzyme inhibition and induction properties.
  • Investigation of cytochrome P450 (CYP450) genotypic variants.

    • Main Results:

    • Detailed metabolic pathways and P-glycoprotein interactions for key GI drugs.
    • Specific drug-drug interactions identified for PPIs, H2 blockers, and 5-HT3 antagonists.
    • CYP450 genetic polymorphisms significantly influence drug effectiveness and interaction risks.

    Conclusions:

    • GI drug efficacy and safety are influenced by metabolic pathways and genetic factors.
    • Awareness of drug-drug interactions, including with psychotropic medications, is essential.
    • Personalized medicine approaches considering pharmacogenetics can optimize GI drug therapy.